FacebookLinkedInRssXYouTube

RetroSense

RetroSense Therapeutics’ Investors See Exit, Bright Future Ahead

ANN ARBOR - An investment made by several groups of early-stage Michigan investors could pay off in a big way following the recent news that Allergan acquired Ann Arbor-based RetroSense Therapeutics LLC, a Michigan angel-backed gene therapy company, for $60 million plus additional funding if the company reaches future milestones. Terry Cross, MVCA member, and

By |2016-09-09T12:18:18-04:00September 9th, 2016|Entrepreneurs, Life Sciences|
Read More

RetroSense Therapeutics Begins Clinical Trials For Drug To Restore Vision

ANN ARBOR - RetroSense Therapeutics, a privately-held biopharmaceutical company, announced Monday the first patient has been successfully dosed in the first clinical trial to evaluate the safety of of a drug to restore some vision for people suffering from Retinitis Pigmentosa, which can result in vision loss and blindness. “Successfully dosing our first patient with

By |2016-03-24T17:25:42-04:00March 24th, 2016|Life Sciences|
Read More